SMMT
Summit Therapeutics Inc.
PDUFA
Confirmed
ivonescimab
EGFR-mutated locally advanced or metastatic non-squamous NSCLC postβTKI therapy
T-minus 11 days
Nov 14, 2026
SEC 8-K
verified 4mo ago
Countdown card β